Clinical trial
Contrast- Enhanced Whole-Heart Coronary Magnetic Resonance Angiography (MRA) at 3.0T
NCT02092428 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Contrast- Enhanced Whole-Heart Coronary Magnetic Resonance Angiography (MRA) at 3.0T
- Lead sponsor
- Cedars-Sinai Medical Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 30, 2011
- Completion date
- March 1, 2017
- Enrollment
- 333 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.